Talimogene and Atezolizumab Trial in HER2-Negative Breast Cancer
In a remarkable stride toward advancing cancer immunotherapy, a recent phase II clinical trial has illuminated the promising synergy between ...
In a remarkable stride toward advancing cancer immunotherapy, a recent phase II clinical trial has illuminated the promising synergy between ...
In a groundbreaking study that could reshape the therapeutic landscape of colorectal cancer, researchers have unveiled a novel approach that ...
At the forefront of gynecologic oncology, a significant breakthrough is poised to reshape the clinical landscape for women battling platinum-resistant ...
In an era where personalized medicine intertwines with cutting-edge technology, the latest research showcases a groundbreaking approach to treating one ...
Recent advancements in nanomedicine have dramatically shifted the paradigm of cancer therapy, particularly in how we approach the tumor microenvironment ...
In the rapidly evolving field of cancer immunotherapy, a newly published study in Nature Communications from 2026 has shed groundbreaking ...
Gastric cancer, a prevalent form of malignancy, continues to pose significant challenges in oncological treatment, primarily due to its dismal ...
In recent years, the field of oncology has witnessed a surge in exploring the molecular intricacies underlying cancer development, with ...
In a groundbreaking development in the realm of cancer immunotherapy, a recent Phase II clinical trial has unveiled promising results ...
In a groundbreaking advancement at the intersection of microbiology and oncology, researchers have unveiled a novel approach to cancer immunotherapy ...
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine